Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for healthcare industry professionals · Wednesday, July 18, 2018 · 455,866,349 Articles · 3+ Million Readers

Asia Pacific Pharma Market To Grow At Over 8% A Year To 2021, Says TBRC

Pharmaceutical Market Growth Rates By Region

Pharmaceutical Market Growth Rates By Region

LONDON, GREATER LONDON, UK, April 24, 2018 /EINPresswire.com/ -- The Asia Pacific market for drugs to treat all medical conditions will be worth $277 billion in 2021, having grown from $200 billion in 2017, a report from The Business Research Company shows. By 2021 the Asia Pacific market, which was already in 2017 the second largest in the world after North America, will have increased its lead over Western Europe in third place and made gains on North America.

The size and growth of a regional market such as Asia Pacific's for drugs as a whole are related to many factors - the size of the population, and especially of the older population, of course, and GDP per capita, but also regulatory systems and physician attitudes as well as disease incidence. New drugs tend to be more expensive, while those out of patent can see their price lowered dramatically by the advent of generics, which have seen major growth in India and China. Markets for drugs that can be bought without a prescription, such as many for respiratory illnesses such as colds, can grow rapidly as this region's population becomes increasingly urban and gains access to pharmacies.

The global pharma market as a whole was worth $935 billion in 2017 and will reach $1170 billion in 2021, growing at 5.8%, an accelerated pace compared to its 5.2% a year growth for the years before 2017.

The pharmaceutical drugs industry includes establishments that develop drugs to diagnose, cure, treat or prevent diseases. Pharmaceutical companies produce both generic and branded drugs. Pharmaceutical drugs are subject to a number of laws and regulations that deal with patenting, testing, safety, efficacy and marketing and affect the size and growth rates of the market. Pharmaceutical companies produce pharmaceutical drugs made from active pharmaceutical ingredients (API) and excipients.

The leading pharma companies are Swiss company Novartis, with just under 5% of the global market in 2017, followed by Sanofi, which is French, then Hoffmann-La Roche, Swiss again. The top ten pharmaceutical manufacturers shared a little over 30% of the global market between them.

Where to Learn More
Read the Pharmaceutical Drugs Market Report from The Business Research Company for information on the following:
Markets Covered: Musculoskeletal Disorder Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-urinary Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs, Drugs For Respiratory Diseases.
Pharmaceutical Companies Mentioned: Novartis AG, Sanofi S.A., F. Hoffman-La Roche Ltd., Pfizer Inc. and Gilead Sciences Inc.
Countries: India, China, Japan, Australia, UK, Germany, France, Italy, Spain, Russia, USA, Brazil
Regions: North America, South America, Western Europe, Eastern Europe, Africa, Middle East, Asia Pacific
Time Series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, population, GDP, Pharmaceutical Drugs Indicators Comparison.
Data Segmentations: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report are sourced using endnotes.

Oliver Guirdham
The Business Research Company
+44 207 1930 708
email us here

Powered by EIN Presswire